[DICER1 syndrome: clinical variety endocrine manifestations and features of diagnostics].


Journal

Problemy endokrinologii
ISSN: 2308-1430
Titre abrégé: Probl Endokrinol (Mosk)
Pays: Russia (Federation)
ID NLM: 0140673

Informations de publication

Date de publication:
16 Oct 2023
Historique:
received: 13 10 2023
accepted: 29 11 2023
revised: 28 11 2023
medline: 26 5 2024
pubmed: 26 5 2024
entrez: 26 5 2024
Statut: epublish

Résumé

DICER1 syndrome is a rare genetic disorder with the progressive development of malignant and non-malignant diseases in childhood. The cause of this syndrome is a dusfunction of the endoribonuclease DICER, which plays an important role in the processing of microRNAs with subsequent regulation of the control of the expression of oncogenes and tumor suppressor genes. Clinical manifestations of dyseropathies is very different and may include both endocrine manifestations - multinodular goiter, differentiated thyroid cancers, ovarian stromal tumors, pituitary blastoma, and non-endocrine formations - pleuropulmonary blastoma, cystic nephroma, pineoblastoma. The presence of somatic mutations of the DICER1 gene is a resultant stage in the pathogenesis of dyseropathies, determining the further path of oncogenesis. At present, DICER1 syndrome is diagnosed extremely rarely, which leads to late detection of the components of the disease in the patient, late diagnosis of neoplasms, lack of family counseling. Diagnosis at the early stages of the disease, the development of screening programs for the management of these patients allows minimizing the risks of developing more malignant, aggressive forms of the disease.

Identifiants

pubmed: 38796764
doi: 10.14341/probl13383
doi:

Substances chimiques

Ribonuclease III EC 3.1.26.3
DICER1 protein, human EC 3.1.26.3
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Review

Langues

rus

Sous-ensembles de citation

IM

Pagination

78-85

Auteurs

E E Novokreshennih (EE)

Endocrinology Research Centre.

A A Kolodkina (AA)

Endocrinology Research Centre.

O B Bezlepkina (OB)

Endocrinology Research Centre.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH